143 filings
Page 3 of 8
EFFECT
tw4hq3e0p6foudumhb
24 Aug 23
Notice of effectiveness
12:15am
CORRESP
qbxaysyduwt4gqppz8
21 Aug 23
Correspondence with SEC
12:00am
UPLOAD
2fdzc ooz8l0ywj1nt7
18 Aug 23
Letter from SEC
12:00am
S-3
c02ij8co3 f1f
14 Aug 23
Shelf registration
6:05pm
8-K
0y2xuq226p0bknl0
8 Aug 23
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
RW
4633u mbl7voig
18 Jul 23
Registration withdrawal request
8:59am
FWP
p8ke45hcswe dv3cic
11 Jul 23
Free writing prospectus
12:42pm
8-K
xd0jez r87i
11 Jul 23
MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer
10:26am
8-K
72cd6wswze6d
10 Jul 23
MAIA Biotechnology Reports Updates on Preliminary Survival Data for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer
4:41pm
S-8
hhs 91x1cw
30 Jun 23
Registration of securities for employees
4:56pm
8-K
4wqxxe0hlyxwzso4p
20 Jun 23
Regulation FD Disclosure
9:06am
FWP
guf3qwd8fyj
9 Jun 23
Free writing prospectus
6:47am
DRS
yxsnpv401h1d13xa
1 Jun 23
Draft registration statement
12:00am
8-K
ea1yay8 4y9l
26 May 23
Submission of Matters to a Vote of Security Holders
6:20pm
8-K
4em95f2n5yq5a t68b3e
8 May 23
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
rvmjrqh2 90t
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
424B3
29u5aip3xmnoa4qh
27 Apr 23
Prospectus supplement
7:22am